Prosecution Insights
Last updated: November 04, 2026

Cardiovol LLC

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Cardiovol LLC operates in the Medical Devices & Mechanical Engineering technology area. There is currently 1 pending office action associated with the company's portfolio. This action is being handled within 1 distinct art unit, which suggests a concentrated technical focus for the company's current patenting efforts. The use of 1 distinct art unit allows for a consistent application of technical standards to the pending matter.

The company's prosecution involves 1 distinct examiner. JIAN, SHIRLEY XUEYING is the busiest examiner for the portfolio, with 1 pending office action. This figure matches the total number of pending office actions for the company. Having JIAN, SHIRLEY XUEYING as the sole examiner for the portfolio workload enables the company to focus its communication and strategy on the specific preferences of this examiner in the Medical Devices & Mechanical Engineering area.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JIAN, SHIRLEY XUEYING 1 63.4% +22.6%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18605649 Method and Apparatus for Assisting a Heart JIAN, SHIRLEY XUEYING —

Top Art Units

Art UnitApps
3792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18605649 Method and Apparatus for Assisting a Heart JIAN, SHIRLEY XUEYING 3792 §112 Non-Final OA — Pending Mar 14, 2024

Managing Cardiovol LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cardiovol LLC have?

Cardiovol LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Cardiovol LLC applications?

Shirley Xueying Jian has the most, with 1 of Cardiovol LLC's pending office actions.

What technology area are Cardiovol LLC's patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month